These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 23943493)

  • 1. Purinergic signalling in the musculoskeletal system.
    Burnstock G; Arnett TR; Orriss IR
    Purinergic Signal; 2013 Dec; 9(4):541-72. PubMed ID: 23943493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of purinergic signalling in the musculoskeletal system.
    Orriss IR
    Auton Neurosci; 2015 Sep; 191():124-34. PubMed ID: 25979767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures.
    Ryten M; Yang SY; Dunn PM; Goldspink G; Burnstock G
    FASEB J; 2004 Sep; 18(12):1404-6. PubMed ID: 15231720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors.
    Orriss IR; Key ML; Brandao-Burch A; Patel JJ; Burnstock G; Arnett TR
    Bone; 2012 Sep; 51(3):389-400. PubMed ID: 22749889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signalling and bone remodelling.
    Orriss IR; Burnstock G; Arnett TR
    Curr Opin Pharmacol; 2010 Jun; 10(3):322-30. PubMed ID: 20189453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular ATP signaling and clinical relevance.
    Dou L; Chen YF; Cowan PJ; Chen XP
    Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
    Orriss IR; Key ML; Hajjawi MO; Arnett TR
    PLoS One; 2013; 8(7):e69057. PubMed ID: 23874866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pannexin 3 channels in health and disease.
    O'Donnell BL; Penuela S
    Purinergic Signal; 2021 Dec; 17(4):577-589. PubMed ID: 34250568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signalling: past, present and future.
    Burnstock G
    Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
    Dubyak GR; el-Moatassim C
    Am J Physiol; 1993 Sep; 265(3 Pt 1):C577-606. PubMed ID: 8214015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular nucleotides and nucleosides as signalling molecules.
    Giuliani AL; Sarti AC; Di Virgilio F
    Immunol Lett; 2019 Jan; 205():16-24. PubMed ID: 30439478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to Purinergic Signaling.
    Burnstock G
    Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of purinergic receptor polymorphisms in human bone.
    Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signalling: pathophysiology and therapeutic potential.
    Burnstock G
    Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to Purinergic Signalling in the Brain.
    Burnstock G
    Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA.
    Volonté C; Parisi C; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):751-67. PubMed ID: 22963439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic receptors in skeletal muscles in health and in muscular dystrophy.
    Krasowska E; Róg J; Sinadinos A; Young CN; Górecki DC; Zabłocki K
    Postepy Biochem; 2014; 60(4):483-9. PubMed ID: 25807827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introductory overview of purinergic signalling.
    Burnstock G
    Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
    Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
    FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.